secwatch / observer
8-K filed January 18, 2024, 6:59 PM ET CIK 0001802546
other material confidence high sentiment neutral materiality 0.40

Kona Gold reduces authorized common shares from 10.5B to 5.614B; designates Series E preferred

KONA GOLD BEVERAGE, INC.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

KONA GOLD BEVERAGE, INC.: Decreased authorized common stock from 10,500,000,000 to 5,614,000,000 shares (effective 2023-12-30).

Change
charter amendment
Effective
2023-12-30
Exact text from the filing
On December 30, 2023, Kona Gold Beverage, Inc. (the “Company”). filed with the Secretary of State of the State of Delaware a Certificate of Amendment to its amended and restated Certificate of Incorporation (the “Certificate of Amendment”) to decrease the number of the Company’s authorized shares of common stock, par value $0.00001 per share (the “Common Stock”), from ten billion five hundred million (10,500,000,000) shares to five billion six hundred fourteen million (5,614,000,000) shares.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

KONA GOLD BEVERAGE, INC.: Filed Series E Certificate of Designation to designate 8,000,000 shares of Series E Preferred Stock (effective 2023-11-30).

Change
charter amendment
Effective
2023-11-30
Exact text from the filing
On November 30, 2023, the Company filed with the Secretary of State of the State of Delaware a Certificate of Designation of the Preferences, Rights, and Limitations of the Series E Preferred Stock (the “Series E Certificate of Designation”) to designated 8,000,000 shares of such, par value $0.00001 per share.
View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR
accession 0001493152-24-002837
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.